With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical ...

Klotho Neurosciences ( ($KLTO) ) has provided an announcement. On July 10, 2025, Klotho Neurosciences announced that the FDA granted Orphan Drug ...

Klotho shares have soared more than 1000% over the past three months on promising results and breakthrough hopes.

Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading ...

Boosting Klotho protein levels in mice improves physical and cognitive aging, offering potential for future longevity ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Detailed price information for Klotho Neurosciences Inc (KLTO-Q) from The Globe and Mail including charting and trades.

Klotho Neurosciences moves forward with manufacturing gene therapy to treat amyotrophic lateral sclerosis: New York Tuesday, July 1, 2025, 15:00 Hrs [IST] Klotho Neurosciences, In ...

US stock market today saw a strong start as Dow, S&P 500, and Nasdaq futures climbed on hopes of trade deal progress.